Clinical Trial

Effect Of Resistive Capactive Electrical Transfer Therapy In Difficult-to-heal Wounds

Unknown
View on ClinicalTrials.gov →
Summary
Difficult-to-heal wounds present imbalances in cytokine production, increases in MMP expression, high levels of apoptosis, and decreases in the proliferation of cells such as fibroblasts and keratinocytes, which are involved in tissue regeneration. CRET therapy (capacitive resistive electrical transfer therapy) has been shown to generate granulation tissue in in vitro assays. In addition, available clinical case reports and preliminary clinical trial results indicate that CRET can promote the regeneration of acute wounds and DHW (difficult-to-heal wounds).
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05953935
Lead Sponsor Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Conditions Difficult-to-heal Wounds
Enrollment 137 participants
Start Date 2024-01-31
Primary Completion 2024-07-31 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-09-19